Abstract
Nonmotor symptoms (NMS) of idiopathic Parkinson’s disease (IPD), specifically fatigue, depression and sleep disturbances, are important contributors for worse quality of life and poor patient outcomes. The aim of this research is to determine the relationship between fatigue and other NMS and the independent effect of fatigue on health-related quality of life (HRQoL) in patients with IPD. 86 IPD patients and 85 healthy individuals were included in our study. Participants were evaluated by their answers to the Beck Depression Inventory, Fatigue Severity Scale, Epworth Sleepiness Scale and Parkinson’s Disease Questionnaire-39. Hoehn–Yahr stage, disease duration, medications and demographical characteristics were also noted. ROC analysis was used to determine the cutoff point for HRQoL. Nonparametric Spearman correlation analysis was used for determining the relationship between variables. Independent factors which affect HRQoL were detected by multiple forward stepwise logistic regression analysis. NMS were associated with each other and with HRQoL when they act concomitantly (p < 0.001). Of these three frequent NMS, depression (p < 0.05) and fatigue (p < 0.001) had independent worsening effect on HRQoL, whereas sleep disturbances did not (p > 0.05). The stage of IPD and levodopa–entacapone treatment had independent effects on HRQoL too (p < 0.05). Fatigue was found as the most important factor which affects HRQoL among all investigated NMS. So, it is important to ask about fatigue in routine controls of IPD patients and try to treat it for improving life quality.
Similar content being viewed by others
References
George S, Rey NL, Reichenbach N, Steiner JA, Brundin P (2013) α-Synuclein: the long distance runner. Brain Pathol 3(3):350–357
Opara JA, Brola W, Leonardi M, Blaszczyck B (2012) Quality of life in Parkinson’s disease. J Med Life 5(4):375–381
Martinez-Martin P, Rodriguez-Blazquez C, Forjaz MJ, Alvarez-Sanchez M, Arakaki T, Bergareche-Yarza A, Chade A, Garretto N, Gershanik O, Kurtis MM, Martinez-Castrillo JC, Mendoza-Rodriguez A, Moore HP, Rodriguez Violante M, Singer C, Tilley BC, Huang J, Stebbins GT, Goetz CG (2014) Relationship between the MDS-UPDRS domains and the health related quality of life of Parkinson’s disease patients. Eur J Neurol 21(3):519–524
Romani A (2008) The treatment of fatigue. Neurol Sci 29(2):247–249
Greim B, Benecke R, Zettl UK (2007) Qualitative and quantitative assessment of fatigue in multiple sclerosis (MS). J Neurol 254(2):II58–II64
Pfeiffer RF (2007) Non-motor parkinsonism. Parkinsonism Relat Disord 13(3):211–220
Mendonça DA, Menezes K, Jog MS (2007) Methylphenidate improves fatigue scores in Parkinson’s disease: a randomized controlled trial. Mov Disord 22(14):2070–2076
Datieva VK, Rosinskaia AV, Levin OS (2013) The use of melatonin in the treatment of chronic fatigue syndrome and circadian rhythm disorders in Parkinson’s disease. Zh Nevrol Psikhiatr Im S S Korsakova 113(7 Pt 2):77–81
Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD (1989) The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46(10):1121–1123
Izci B, Ardic S, Fırat H, Sahin A, Altınors M, Karacak I (2008) Reliability and validity studies of the Turkish version of the Epworth Sleepiness Scale. Sleep Breath 12:161–168
Beck Aaron T (1998) Psychometric properties of the Beck Depression Inventory: twenty five years of evaluation. Clin Psychol Rev 8(1):77–100
The Global Parkinson’s Disease Survey (GPDS) Steering Committee (2002) Factors impacting on quality of life in Parkinson’s disease: results from an international survey. Mov Disord 17(1):60–67
Peto V, Jenkinson C, Fitzpatrick R et al (1995) The development and validation of a short measure of functioning and well being for individuals with Parkinson’s disease. Qual Life Res 4:241–248
Shulman LM, Taback RL, Bean J, Weiner WJ (2001) Comorbidity of the nonmotor symptoms of Parkinson’s disease. Mov Disord 16(3):507–510
Okuma Y, Kamei S, Morita A, Yoshii F, Yamamoto T, Hashimoto S, Utsumi H, Hatano T, Hattori N, Matsumura M, Takahashi K, Nogawa S, Watanabe Y, Miyamoto M, Hirata K (2009) Fatigue in Japanese patients with Parkinson’s disease: a study using Parkinson fatigue scale. Mov Disord 24(13):1977–1983
Kang SY, Ma HI, Lim YM, Hwang SH, Kim YJ (2013) Fatigue in drug-naive Parkinson’s disease. Eur Neurol 70(1–2):59–64
Friedman JH, Friedman H (1993) Fatigue in Parkinson’s disease. Neurology 43:2016–2018
Stocchi F, Abbruzzese G, Ceravolo R, Cortelli P, D’Amelio M, De Pandis MF, Fabbrini G, Pacchetti C, Pezzoli G, Tessitore A, Canesi M, Iannacone C, Zappia M, FORTE Study Group (2014) Prevalence of fatigue in Parkinson’s disease and it’s clinical correlates. Neurology 83(3):215–220
Oved D, Ziv I, Treves TA, Paleacu D, Melamed E, Djaldetti R (2006) Effect of dopamine agonists on fatigue and somnolence in Parkinson’s disease. Mov Disord 21(8):1257–1261
Karlsen K, Larsen JP, Tandberg E, Jorgessen K (1999) Fatigue in patients with Parkinson’s disease. Mov Disord 14(2):237–241
Alves G, Wentzel-Larsen T, Larsen JP (2004) Is fatigue an independent and persistant symptom in patients with Parkinson’s disease? Neurology 63(10):1908–1911
Lou JS, Dimitrova DM, Park BS, Johnson SC, Eaton R, Arnold G, Nutt JG (2009) Using modafinil to treat fatigue in Parkinson’s disease: a double blind, placebo-controlled pilot study. Clin Neuropharmacol 32(6):305–310
Elbers RG, van Wegen EE, Verhoef J, Kwakkel G (2014) Impact of fatigue on health-related quality of life in patients with Parkinson’s disease: a prospective study. Clin Rehabil. 28(3):300–311
Song W, Guo X, Chen K, Chen X, Cao B, Wei Q, Huang R, Zhao B, Wu Y, Shang HF (2014) The impact of nonmotor symptoms on the health related quality of life of Parkinson’s disease patients from Southwest China. Parkinsonism Relat Disord 20(2):149–152
Mao CJ, Cao LD, Tang Q, Liu CF (2013) Observations on fatigue, depression and quality of life in patients with Parkinson’s disease. Zhonghua Nei Za Zhi 52(3):200–202
Acknowledgments
No funding source was used during the research. No other people than researchers participated in this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
We have no potential conflict of interest.
Rights and permissions
About this article
Cite this article
Dogan, V.B., Koksal, A., Dirican, A. et al. Independent effect of fatigue on health-related quality of life in patients with idiopathic Parkinson’s disease. Neurol Sci 36, 2221–2226 (2015). https://doi.org/10.1007/s10072-015-2340-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-015-2340-9